Table: JCR Pharmaceuticals -6-MTH group results

JCR Pharmaceuticals

29/10/2026 06:30

Oct 29 (Reuters)-
JCR Pharmaceuticals
CONSOLIDATED FINANCIAL HIGHLIGHTS

 (in billions of yen unless specified)

              6 months ended  6 months ended    Year to
              Sep 30, 2026    Sep 30, 2025   Mar 31, 2027
                 LATEST         YEAR-AGO        LATEST
                RESULTS         RESULTS        FORECAST
Sales            19.97           21.36          45.70
               (-6.5 pct)     (+28.2 pct)    (+13.3 pct)
Operating      loss 3.50          2.43           1.10
                                             (+98.2 pct)
Recurring      loss 3.80          2.41         500 mln
                                             (-57.1 pct)
Net            loss 3.87          1.75         200 mln
                                             (-90.8 pct)
EPS          loss 31.67 yen    14.32 yen       1.64 yen
EPS Diluted        --          14.31 yen          --
Ann Div            --          20.00 yen      20.00 yen
-Q2 div        10.00 yen       10.00 yen          --
-Q4 div            --          10.00 yen      10.00 yen


 NOTE - JCR Pharmaceuticals.

To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4552.T